Amgen posts higher third-quarter revenue and profit
By Deena Beasley (Reuters) -Biotechnology company Amgen Inc (NASDAQ:AMGN) on Thursday said its third-quarter revenue rose 1% as higher volume growth for its cancer, rheumatology and cardiovascular products was offset…